-
Posted by
Two Blokes Fri at 12:00 PM -
Filed in
Stock
-
2 views
Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , May 9, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx\u00ae plant cell-based protein expression system, today reported financial results for the quarter ended March 31, 2025, and provided a business and clinical update.
